HomeDRMA • NASDAQ
add
Dermata Therapeutics Inc
Previous close
$3.03
Day range
$3.03 - $3.03
Year range
$2.36 - $23.70
Market cap
3.11M USD
Avg Volume
53.78K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.76M | -45.42% |
Net income | -1.69M | 46.68% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.66M | -24.08% |
Total assets | 5.07M | -24.16% |
Total liabilities | 1.11M | -42.90% |
Total equity | 3.96M | — |
Shares outstanding | 1.03M | — |
Price to book | 0.65 | — |
Return on assets | -75.17% | — |
Return on capital | -91.95% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.69M | 46.68% |
Cash from operations | -1.80M | 47.24% |
Cash from investing | — | — |
Cash from financing | -12.99K | -100.28% |
Net change in cash | -1.82M | -251.82% |
Free cash flow | -1.23M | 44.85% |
About
Founded
2014
Website
Employees
8
